• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by DocGo Inc.

    2/28/25 4:28:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email
    S-8 1 docgo-formsx82025.htm S-8 Document

    As filed with the Securities and Exchange Commission on February 28, 2025

    Registration No. 333-
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM S-8
    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

    DOCGO INC.
    (Exact name of registrant as specified in its charter)

    Delaware
    (State or Other Jurisdiction of Incorporation or Organization)
    85-2515483
    (I.R.S. Employer Identification No.)

    DocGo Inc.
    685 Third Avenue, 9th Floor
    New York, New York 10017
    (Address of Principal Executive Offices, Zip Code)

    DocGo Inc. 2021 Stock Incentive Plan
    (Full title of the plan)

    Ely D. Tendler
    General Counsel and Secretary
    DocGo Inc.
    685 Third Avenue, 9th Floor
    New York, New York 10017
    (844) 443-6246
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
    With a copy to:
    Gina Hancock
    Gibson, Dunn & Crutcher LLP
    2001 Ross Avenue, Suite 2100
    Dallas, TX 75201
    (214) 698-3100
    Julia Lapitskaya
    Gibson, Dunn & Crutcher LLP
    200 Park Avenue
    New York, NY 10166
    (212) 351-4000
    ______________________________________________

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
     
    Large accelerated filer☐Accelerated filer☒
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
     


     


    EXPLANATORY NOTE
    This Registration Statement on Form S-8 (this “Registration Statement”) is being filed by DocGo Inc. (the “Company”) for the purpose of registering an additional (i) 12,335,088 shares of common stock, par value $0.0001 per share, of the Company (“Common Stock”) that became issuable under the DocGo Inc. 2021 Stock Incentive Plan (the “Plan”) pursuant to the provisions of the Plan providing for automatic increases in the number of shares reserved for issuance thereunder (the “Evergreen Shares”) and (ii) 784,944 shares of Common Stock that may again become available for delivery with respect to awards under the Plan pursuant to the share counting, share recycling and other terms and conditions of the Plan (the “Forfeited Shares”).
    The Evergreen Shares and the Forfeited Shares are securities of the same class as other securities for which a Registration Statement on Form S-8 (File No. 333-262108) was filed by the Company with the Securities and Exchange Commission (the “Commission”) on January 11, 2022 (the “Prior Registration Statement”). The Forfeited Shares were previously registered under the Prior Registration Statement and do not represent an increase in the total number of shares of Common Stock that may be issued pursuant to the Plan.
    Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement, to the extent relating to the registration of the Common Stock issuable under the Plan, are incorporated herein by reference and made part of this Registration Statement, except as modified hereby.
    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 5. Interests of Named Experts and Counsel

    The validity of the issuance of the shares of Common Stock registered hereby is passed on for the Company by Ely D. Tendler, General Counsel and Secretary of the Company, who has received awards under the Plan. Mr. Tendler beneficially owns shares of Common Stock.
    Item 8.    Exhibits.

    Exhibit No. Exhibit Description
    4.1 
    Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on November 12, 2021).
    4.2 
    Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 of the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 6, 2023).
    5.1* 
    Opinion of Ely D. Tendler, General Counsel and Secretary of the Company.
    23.1* 
    Consent of Independent Registered Public Accounting Firm.
    23.2* 
    Consent of Ely D. Tendler, General Counsel and Secretary of the Company (included in Exhibit 5.1).
    24.1* 
    Power of Attorney (included on signature page hereto).
    99.1 
    DocGo Inc. 2021 Stock Incentive Plan (incorporated by reference to Exhibit 10.8 of Amendment No. 5 to the Company’s Registration Statement on Form S-4/A filed on October 7, 2021).
    107.1*
    Filing Fee Table.
    * Filed herewith.








     


    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on this 28th day of February, 2025.

    DOCGO INC.

    By:
    /s/ Lee Bienstock
    Name:
    Lee Bienstock
    Title:Chief Executive Officer

    POWER OF ATTORNEY

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Lee Bienstock, Norman Rosenberg and Ely D. Tendler and each of them (with full power to each of them to act alone), the individual’s true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact and agents, or any of them, or their substitutes, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

    Name Title Date
         
    /s/ Lee Bienstock 
    Chief Executive Officer and Director
    (principal executive officer)
     
    February 28, 2025
    Lee Bienstock 
     /s/ Norman Rosenberg
     
    Chief Financial Officer
    (principal financial officer and principal accounting officer)
     
    February 28, 2025
    Norman Rosenberg 
    /s/ Stephen K. Klasko
     
    Director and Chair of the Board
     
    February 28, 2025
    Stephen K. Klasko 
         
    /s/ Michael Burdiek Director 
    February 28, 2025
    Michael Burdiek 
         
    /s/ Vina Leite Director 
    February 28, 2025
    Vina Leite 
         
    /s/ Ira Smedra Director 
    February 28, 2025
    Ira Smedra 
         
    /s/ Ely D. Tendler Director 
    February 28, 2025
    Ely D. Tendler 


     


         
    /s/ James M. Travers Director 
    February 28, 2025
    James M. Travers 


    Get the next $DCGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings

    $DCGO
    Financials

    Live finance-specific insights

    See more
    • DocGo Announces First Quarter 2025 Results

      Company Focuses on Growing Medical Transportation and Payer & Provider Businesses, Navigates Municipal Uncertainty and Migrant Services Transition Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, "The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populati

      5/8/25 4:05:00 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo to Announce First Quarter Results on Thursday, May 8, 2025

      Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 65854 To access the Call me™ feature, which avoids the need to wait for an operator, click https:

      4/21/25 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Announces Fourth Quarter and Full-Year 2024 Results

      Company Surpasses 700,000 Total Patient Lives Assigned for Care Gap Closure Programs and Expands Contracts With Payer Partners on Both Coasts Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter and full-year ended December 31, 2024. Full-Year 2024 Financial Highlights Full-year 2024 revenue was $616.6 million, compared to $624.2 million for the full-year 2023. GAAP gross margin (which includes non-cash depreciation expenses) for the full-year 2024 was 32.1%, compared to 28.7%

      2/27/25 4:11:00 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DocGo Announces First Quarter 2025 Results

      Company Focuses on Growing Medical Transportation and Payer & Provider Businesses, Navigates Municipal Uncertainty and Migrant Services Transition Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, "The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populati

      5/8/25 4:05:00 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo to Announce First Quarter Results on Thursday, May 8, 2025

      Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 65854 To access the Call me™ feature, which avoids the need to wait for an operator, click https:

      4/21/25 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Earns Great Place To Work Certification™ For the Third Time in a Row

      DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced that it has been Certified™ by Great Place To Work® for the third time in a row. This prestigious award is based on what current employees say about their experience working at the Company. This year, employees rated DocGo 31% higher than the average US company as a Great Place to Work. Great Place To Work® is the global authority on workplace culture, employee experience and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. "Our clinicians who bring care to patients where they need it – and the

      3/31/25 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Compliance Officer Sugrue Stephen covered exercise/tax liability with 5,614 shares, decreasing direct ownership by 2% to 347,328 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      4/2/25 4:45:15 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • CFO and Treasurer Rosenberg Norman covered exercise/tax liability with 8,004 shares, decreasing direct ownership by 0.93% to 856,272 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      4/2/25 4:44:31 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Bienstock Lee covered exercise/tax liability with 37,340 shares, decreasing direct ownership by 2% to 1,956,079 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      4/2/25 4:43:52 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Leadership Updates

    Live Leadership Updates

    See more

    $DCGO
    SEC Filings

    See more

    $DCGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • DocGo Acquires PTI Health To Expand Proactive Healthcare Offering with Mobile Lab Collection and Mobile Phlebotomy Services

      DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo's healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options. The acquisition enhances DocGo's offerings

      2/10/25 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board

      DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o

      9/30/24 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Appoints Eiwe Lingefors as New Chief Information Officer

      DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers

      9/26/24 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by DocGo Inc.

      10-Q - DocGo Inc. (0001822359) (Filer)

      5/8/25 4:35:04 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - DocGo Inc. (0001822359) (Filer)

      5/8/25 4:15:49 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • SEC Form SCHEDULE 13G filed by DocGo Inc.

      SCHEDULE 13G - DocGo Inc. (0001822359) (Subject)

      4/30/25 10:53:25 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Burdiek Michael J bought $34,000 worth of shares (10,000 units at $3.40), increasing direct ownership by 2% to 581,595 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/14/24 4:10:44 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Tendler Ely D bought $31,300 worth of shares (10,000 units at $3.13), increasing direct ownership by 7% to 162,933 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/13/24 4:34:19 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Bienstock Lee bought $78,750 worth of shares (25,000 units at $3.15), increasing direct ownership by 2% to 1,220,845 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/13/24 4:30:30 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DocGo downgraded by BTIG Research

      BTIG Research downgraded DocGo from Buy to Neutral

      5/9/25 8:41:42 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

      2/28/25 8:51:46 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • BTIG Research initiated coverage on DocGo with a new price target

      BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00

      8/18/23 7:24:03 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by DocGo Inc.

      SC 13D/A - DocGo Inc. (0001822359) (Subject)

      11/29/24 4:14:57 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by DocGo Inc.

      SC 13G/A - DocGo Inc. (0001822359) (Subject)

      11/14/24 9:56:36 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by DocGo Inc. (Amendment)

      SC 13G/A - DocGo Inc. (0001822359) (Subject)

      3/1/24 4:53:15 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care